Diebold Nixdorf Beats EPS, Misses Revenue; Shares Rise 1.4% After Hours
Diebold Nixdorf (NYSE:DBD) posted Q1 2026 GAAP EPS of $0.14 and non‑GAAP EPS of $0.67, beating consensus by $0.06, while revenue of $892 million fell short of the $846.2 million estimate. The beat on earnings and a strong free‑cash‑flow story sent the stock up 1.42% in after‑hours trading to $77.90.
Earnings Summary
- GAAP EPS: $0.14 vs. $0.08 consensus (beat $0.06)
- Non‑GAAP EPS: $0.67 vs. $0.61 consensus (beat $0.06)
- Revenue: $892 M vs. $846.2 M estimate (miss by $45.8 M, or 5.4%)
- YoY Revenue Growth: 6%
- Free Cash Flow: $20.7 M (non‑GAAP), more than triple YoY
- Net Income: $5.5 M GAAP, turning a profit from a $(0.22) loss a year ago.
The company highlighted a sequentially higher backlog, record free‑cash‑flow for the sixth straight quarter, and continued share repurchases ($55 M in Q1, $117 M remaining under the $200 M program).
Guidance & Outlook
Diebold Nixdorf reaffirmed its FY 2026 outlook, projecting:
- Revenue: $3.86 B–$3.94 B (mid‑point $3.90 B)
- Adjusted EBITDA: $510 M–$535 M
- Free Cash Flow: $255 M–$270 M
- Adjusted EPS: $5.25–$5.75
The guidance sits near the consensus range cited by MarketBeat (revenue $3.9 B, EPS $5.49), signaling confidence that the momentum in banking‑automation and retail‑POS segments will sustain growth.
Conference Call Highlights
CEO Octavio Marquez emphasized disciplined execution and a “fortress balance sheet,” noting:
- Positive free‑cash‑flow for six consecutive quarters.
- Ongoing investments in service performance and innovation.
- Strong pipeline in India’s Fit‑for‑Purpose devices and a major cash‑recycling win in Western Europe.
CFO Tom Timko underscored the expanding adjusted EBITDA margin and the effectiveness of the share‑repurchase program in returning capital to shareholders.
Market Reaction & Analyst Take
The after‑hours price jumped 1.42% to $77.90, the highest intraday level since early March. MarketBeat reported that several analysts nudged their price targets higher, with the median target moving from $80 to $85, citing the EPS beat, robust free‑cash‑flow and the reaffirmed guidance.
Zacks analysts labeled DBD a “good investment” after the release, pointing to the company’s improving profitability and its inclusion in the S&P SmallCap 600 index as a liquidity catalyst.
QuiverQuant’s brief recap noted the EPS beat and highlighted that the revenue miss was “offset by stronger‑than‑expected cash generation and a solid backlog,” reinforcing a bullish stance among small‑cap tech investors.
Investor Takeaways
- Earnings beat on both GAAP and non‑GAAP EPS supports a positive earnings narrative despite a modest revenue shortfall.
- Free cash flow more than tripled YoY, providing ample runway for continued share repurchases and strategic investments.
- Guidance remains at the high end of consensus, suggesting management expects the revenue‑growth tailwinds in banking and retail to persist.
- Analyst sentiment is turning upbeat, with price‑target upgrades and a “good investment” rating from Zacks.
- After‑hours price action (+1.4%) reflects market confidence, but investors should monitor the next quarter’s revenue trajectory, especially in the competitive ATM‑automation space.
The next earnings call is slated for July 30, 2026, when Diebold Nixdorf will reveal whether the Q2 revenue momentum can close the gap with Wall Street expectations.
Key Takeaways
- DBD beat GAAP EPS by $0.06 and non‑GAAP EPS by $0.06, driving a 1.4% after‑hours rally to $77.90.
- Revenue of $892 M missed estimates by ~5.4%, but free cash flow jumped to $20.7 M, more than triple YoY.
- Management reaffirmed FY 2026 guidance (revenue $3.86‑$3.94 B, adjusted EPS $5.25‑$5.75), staying near consensus.
- Analysts upgraded price targets (median $85) and Zacks labeled the stock a good investment after the beat.
- Share repurchase program continues ($55 M this quarter, $117 M remaining), supporting shareholder returns.